BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19092295)

  • 1. RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.
    Siraj AK; Al-Rasheed M; Ibrahim M; Siddiqui K; Al-Dayel F; Al-Sanea O; Uddin S; Al-Kuraya K
    J Endocrinol Invest; 2008 Oct; 31(10):893-9. PubMed ID: 19092295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.
    Siraj AK; Ibrahim M; Al-Rasheed M; Abubaker J; Bu R; Siddiqui SU; Al-Dayel F; Al-Sanea O; Al-Nuaim A; Uddin S; Al-Kuraya K
    BMC Med Genet; 2008 Jul; 9():61. PubMed ID: 18601742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of differentiated thyroid carcinoma with combined effects of homologous recombination repair gene polymorphisms in an Iranian population.
    Fayaz S; Karimmirza M; Tanhaei S; Fathi M; Torbati PM; Fard-Esfahani P
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6727-31. PubMed ID: 24377596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
    Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
    Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
    Chen P; Sun R; Pu Y; Bai P; Yuan F; Liang Y; Zhou B; Wang Y; Sun Y; Zhu J; Zhang L; Gao L
    Medicine (Baltimore); 2015 Sep; 94(38):e1536. PubMed ID: 26402809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-repair genetic polymorphisms and breast cancer risk.
    Smith TR; Levine EA; Perrier ND; Miller MS; Freimanis RI; Lohman K; Case LD; Xu J; Mohrenweiser HW; Hu JJ
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1200-4. PubMed ID: 14652281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk.
    Lee KM; Choi JY; Kang C; Kang CP; Park SK; Cho H; Cho DY; Yoo KY; Noh DY; Ahn SH; Park CG; Wei Q; Kang D
    Clin Cancer Res; 2005 Jun; 11(12):4620-6. PubMed ID: 15958648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma.
    Akulevich NM; Saenko VA; Rogounovitch TI; Drozd VM; Lushnikov EF; Ivanov VK; Mitsutake N; Kominami R; Yamashita S
    Endocr Relat Cancer; 2009 Jun; 16(2):491-503. PubMed ID: 19286843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand.
    Kietthubthew S; Sriplung H; Au WW; Ishida T
    Int J Hyg Environ Health; 2006 Jan; 209(1):21-9. PubMed ID: 16373199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the influence of chronic low-dose radiation on DNA repair gene polymorphisms [
    Saini D; Sudheer KR; Kumar PRV; Soren DC; Jain V; Koya PKM; Jaikrishan G; Das B
    Int J Radiat Biol; 2020 Jun; 96(6):734-739. PubMed ID: 32149571
    [No Abstract]   [Full Text] [Related]  

  • 11. XRCC3 and NBS1 gene polymorphisms modulate the risk of pre-oral cancer and oral cancer in the North Indian population.
    Nigam K; Gupta S; Singh N; Yadav SK; Sanyal S
    J Cancer Res Ther; 2023; 19(2):304-311. PubMed ID: 37006067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic polymorphisms in X-ray repair cross-complementing gene 1 and susceptibility to papillary thyroid carcinoma].
    Zhu QX; Bian JC; Shen Q; Jiang F; Tang HW; Zhang HW; Wu Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):702-5. PubMed ID: 15555397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
    Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Ile3434Thr XRCC7 gene polymorphism in differentiated thyroid cancer risk in an Iranian population.
    Rahimi M; Fayaz S; Fard-Esfahani A; Modarressi MH; Akrami SM; Fard-Esfahani P
    Iran Biomed J; 2012; 16(4):218-22. PubMed ID: 23183621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VDR gene FokI polymorphism as a poor prognostic factor for papillary thyroid cancer.
    Beysel S; Eyerci N; Pinarli FA; Apaydin M; Kizilgul M; Caliskan M; Ozcelik O; Kan S; Cakal E
    Tumour Biol; 2018 Nov; 40(11):1010428318811766. PubMed ID: 30486759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.
    Improta G; Sgambato A; Bianchino G; Zupa A; Grieco V; La Torre G; Traficante A; Cittadini A
    Anticancer Res; 2008; 28(5B):2941-6. PubMed ID: 19031937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of DNA repair genes and risk of glioma.
    Wang LE; Bondy ML; Shen H; El-Zein R; Aldape K; Cao Y; Pudavalli V; Levin VA; Yung WK; Wei Q
    Cancer Res; 2004 Aug; 64(16):5560-3. PubMed ID: 15313891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphic variants of DNA repair gene XRCC3 and XRCC7 and risk of prostate cancer: a study from North Indian population.
    Mandal RK; Kapoor R; Mittal RD
    DNA Cell Biol; 2010 Nov; 29(11):669-74. PubMed ID: 20590474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-strand break repair and colorectal cancer: gene variants within 3' UTRs and microRNAs binding as modulators of cancer risk and clinical outcome.
    Naccarati A; Rosa F; Vymetalkova V; Barone E; Jiraskova K; Di Gaetano C; Novotny J; Levy M; Vodickova L; Gemignani F; Buchler T; Landi S; Vodicka P; Pardini B
    Oncotarget; 2016 Apr; 7(17):23156-69. PubMed ID: 26735576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants in DNA double-strand break repair genes and breast cancer susceptibility.
    Kuschel B; Auranen A; McBride S; Novik KL; Antoniou A; Lipscombe JM; Day NE; Easton DF; Ponder BA; Pharoah PD; Dunning A
    Hum Mol Genet; 2002 Jun; 11(12):1399-407. PubMed ID: 12023982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.